Onkaido Therapeutics
Cambridge
About Onkaido Therapeutics
The Onkaido Therapeutics team is exploring how messenger RNA therapeutics™ can deliver novel oncology drugs to help patients.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $20.0M
- Last round: Series Unknown (Jan 2014)
- Website: onkaido.com
- Phone: +1 617-583-1998
Industries & Categories
Biotechnology, Health Care, Oncology, Therapeutics
Canonical: https://fsome.com/organization/onkaido-therapeutics-354878 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.